Qi Dong Xia

Tongji Hospital

Papers

1

Total Citations

7

H-Index

1

About

Qi Dong Xia is a leading urological surgeon and researcher whose work centers on advancing surgical treatments for prostate cancer, particularly through minimally invasive techniques. His major contributions lie in systematically evaluating the comparative effectiveness of robotic-assisted radical prostatectomy (RARP) against traditional open and laparoscopic approaches. In his highly cited 2024 systematic review and network meta-analysis, Xia synthesized evidence from multiple trials to demonstrate that RARP offers superior perioperative outcomes, including reduced blood loss and shorter hospital stays, while maintaining comparable oncological control. This work has garnered 7 citations in a short time, reflecting its immediate impact on clinical decision-making. Beyond this, Xia’s research portfolio explores optimizing surgical protocols and patient selection for robotic surgery, helping to establish RARP as a gold-standard treatment for localized prostate cancer. His achievements include integrating evidence-based practice into urology training programs and contributing to international guidelines on prostate cancer management. For students and researchers, Xia exemplifies how rigorous meta-analytic methods can translate into tangible improvements in surgical care, making his work essential reading for anyone interested in the future of urologic oncology and robotic surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
A clinical evaluation of robotic-assisted radical prostatectomy (RARP) in located prostate cancer: A systematic review and network meta-analysis
7 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Tongji Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago